Shire PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shire PLC with three other
pharmaceutical manufacturers in Europe:
Novo Nordisk As
sales of 111.70 billion Danish Kroner [US$18.43 billion]
of which 83%
was Diabetes Care),
(15.33 billion Euro [US$18.83 billion]
of which 46%
was Healthcare), and
(£17.25 billion [US$24.06 billion]
of which 100%
During the year ended December of 2017, sales at
Shire PLC were £11.64 billion (US$16.24 billion).
increase of 37.4%
versus 2016, when the company's sales were £8.48 billion.
This was the fifth consecutive year of sales increases at Shire PLC
(and since 2012, sales have increased a total of 296%).